Devices and Diagnostics

OIS board member Jim Mazzo joins Carl Zeiss Meditec

Carl Zeiss Meditec Taps Mazzo To Lead Consolidated Unit

By Rich Kirkner | July 27, 2016

Carl Zeiss Meditec has moved to consolidate its diagnostic and surgical products in ophthalmology and has brought in well-known ophthalmology industry veteran, James V. Mazzo,…

Read More
Google–Moorfields Venture Eyes AI to Speed Diagnosis with OCT

Google–Moorfields Venture Eyes AI to Speed Diagnosis with OCT

By Priscilla Villarreal | July 26, 2016

Google’s DeepMind Health artificial intelligence project and Moorfields Eye Hospital in London have teamed up for a five-year venture to develop an algorithm using one…

Read More

Is Surprising Raindrop Approval a Sign of Friendlier FDA?

By Larry Haimovitch | July 21, 2016

One of the takeaways that ophthalmic innovators might be reading into the unexpected and somewhat sudden approval of the Raindrop Near Vision Inlay is that…

Read More
OIS - Eye on Five

Eye on Five – May Edition

By Tom Salemi | June 3, 2016

Burden of Eye Problems to Double By 2050 Researchers at the University of Southern California (USC) Roski Eye Institute reported in JAMA Ophthalmology that the…

Read More
Mixing MIGS and Meds - Eye On Innovation Article

Mixing MIGS & Meds

By Michelle Dalton | May 3, 2016

Long gone are the days where glaucoma surgery meant an invasive procedure with the likelihood of a serious complication developing down the road – while…

Read More
OIS - Eye on Five

Eye on Five – April Edition

By Tom Salemi | April 27, 2016

FDA Approves Avedro Corneal Collagen Cross-linking Platform The US Food and Drug Administration finally gave a green light to Avedro Inc. for its KXL System,…

Read More
Avedro Finally Secures FDA Approval - Eye on Innovation Article

Avedro Finally Secures FDA Approval

By Tom Salemi | April 19, 2016

On Monday, Avedro Inc. announced the US Food and Drug Administration finally gave a green light for its KXL System in corneal collagen cross-linking for…

Read More
Argus II Implant as Good at 5 Years as It Is at 3 - Eye on Innovation

Second Sight’s Argus II Shows Strong Performance at the Five-Year Mark

By Rich Kirkner | March 2, 2016

With news that the global market for retinal implants is expected to skyrocket to $1.1 billion by 2022, investigators of Second Sight Medical Products’ Argus…

Read More
OIS - Eye on Five

Eye on Five – February Edition 2016

By Rich Kirkner | February 29, 2016

The Transcend acquisition tops the list, but February was a promising month for ophthalmology. Alcon Leaps into MIGS with Transcend With its acquisition of Transcend…

Read More

Alcon Makes Big Move in MIGS

By OIS Contributor | February 23, 2016

With Transcend, Alcon Gains a Foothold in Glaucoma Device Market Contributed by Larry Haimovitch and Richard Mark Kirkner With its move to acquire Transcend Medical…

Read More
Drugs & Devices for Dry Eye - Ophthalmology Innovation Summit 2015

2016 Promises to Disrupt Dry Eye

By Michelle Dalton | February 16, 2016

This year promises to deliver disruption to the dry eye disease market as companies work to roll out new drugs, devices, and diagnostics. Shire may…

Read More
Close-Up Look at Progress in Surgical Presbyopia Correction - OIS News

Close-Up Look at Progress in Surgical Presbyopia Correction

By Michael Lachman | February 10, 2016

Presbyopia, the age-related loss of accommodation and near/reading vision, typically begins at about age 40 and affects nearly everyone over age 50. This huge opportunity…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.